UBS’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-1,300
Closed -$16K 6625
2014
Q2
$16K Sell
1,300
-50,876
-98% -$626K ﹤0.01% 5434
2014
Q1
$726K Buy
+52,176
New +$726K ﹤0.01% 2890